Uriel Sandkovsky, MD, MS
NPI 1104060904 · Infectious Disease Physician · Dallas, TX
Enrolled with Medicare as Practitioner - Infectious Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1104060904
- Entity type
- Individual
- Primary specialty
- Infectious Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, MS
- Sex
- Male
- Sole proprietor
- No
- License
- R5933 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
3,464 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 1,376 | $116 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 872 | $77 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 373 | $112 |
| Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223 | 317 | $168 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, 1 Hour Or Less96365 | 247 | $62 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ertapenem Sodiumbrand: Ertapenem | 129 | 43 |
| Ceftriaxone Sodiumbrand: Ceftriaxone | 126 | 34 |
| Daptomycin | 105 | 34 |
| Isoniazid | 104 | 22 |
| Bictegrav/Emtricit/Tenofov Alabrand: Biktarvy | 56 | — |
| Fluconazole | 49 | 13 |
| Minocycline Hcl | 35 | 23 |
| Dolutegravir Sodium/Lamivudine |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$108,914 across 202 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-04-23
- Last updated
- 2025-06-05
- Certified
- 2025-06-05
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.